Effect of prostate-specific antigen screening on metastatic disease burden 10 years after diagnosis.

[1]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[2]  J. Ciezki,et al.  The importance of serum prostate-specific antigen testing frequency in assessing biochemical and clinical failure after prostate cancer treatment. , 2010, Urology.

[3]  B. G. Blijenberg,et al.  Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.

[4]  A. Miller,et al.  Mortality results from a randomized prostate-cancer screening trial. , 2009, The New England journal of medicine.

[5]  F. Hamdy,et al.  Population‐based prostate‐specific antigen testing in the UK leads to a stage migration of prostate cancer , 2009, BJU international.

[6]  Harry J de Koning,et al.  Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC). , 2009, European urology.

[7]  John T. Wei,et al.  Quality of life and satisfaction with outcome among prostate-cancer survivors. , 2008, The New England journal of medicine.

[8]  J. Hugosson,et al.  Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer--results from a prospective, population-based randomized controlled trial. , 2007, European urology.

[9]  Kazuto Ito,et al.  Lead time of prostate cancer detected in population based screening for prostate cancer in Japan. , 2005, The Journal of urology.

[10]  J. Ortonne,et al.  Executive Committee Report , 1997 .

[11]  Sajal Gupta,et al.  Glickman Urological and Kidney Institute , 2013 .

[12]  C. Lawton.  Cost-Effectiveness of Prostate Specific Antigen Screening in the United States: Extrapolating From the European Study of Screening for Prostate Cancer , 2012 .

[13]  Liying Zhang,et al.  Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Anthony D'Amico,et al.  Prostate cancer. Clinical practice guidelines in oncology. , 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

[15]  Richard Doll,et al.  Education and debate , 1997 .

[16]  A. Vickers,et al.  Estimating the benefits of PSA screening , 2022 .